Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary pulmonary lymphoma]

J Cadranel1, M Antoine, A Bellocq

  • 1Service de Pneumologie et de Réanimation Respiratoire, Hôpital Tenon, Paris.

Revue Des Maladies Respiratoires
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Which physical tests for which objectives in pulmonary rehabilitation?]

Revue des maladies respiratoires·2021
Same author

[Recommendations of French specialists on screening for lung cancer].

Revue des maladies respiratoires·2021
Same author

Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohort.

HIV medicine·2019
Same author

[IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer].

Revue des maladies respiratoires·2018
Same author

[Structuring the French thoracic oncology over the last 20 years].

Revue des maladies respiratoires·2017
Same author

[Current knowledge on perioperative treatments of non-small cell lung carcinomas].

Revue des maladies respiratoires·2017
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

Primary pulmonary lymphoid proliferations include low-grade B cell lymphomas, high-grade B cell lymphomas, and lymphomatoid granulomatosis. This review details their distinct characteristics, prognoses, and treatment strategies for better patient outcomes.

Area of Science:

  • Pulmonary Medicine
  • Hematology
  • Oncology

Context:

  • Primary pulmonary lymphoid proliferations encompass diverse clinico-anatomical entities.
  • These include low-grade B cell lymphomas, high-grade B cell lymphomas, and lymphomatoid granulomatosis.
  • Distinguishing these entities is crucial due to varied clinical behaviors and prognoses.

Purpose:

  • To review the pathophysiological, diagnostic, prognostic, and therapeutic aspects of primary pulmonary lymphoid proliferations.
  • To clarify the classification and management of these distinct conditions.
  • To provide an updated overview for clinicians managing these rare pulmonary diseases.

Summary:

  • Low-grade B cell pulmonary lymphomas, often indolent and associated with mucosa-associated lymphoid tissue, have an excellent prognosis and varied treatment options (observation, surgery, or single-agent chemotherapy).

Related Experiment Videos

  • High-grade B cell pulmonary lymphomas are rarer, may arise from low-grade precursors or in immunosuppressed individuals, and carry a poor prognosis, with treatment often dictated by the underlying condition.
  • The classification of lymphomatoid granulomatosis within this group is debated; its clonal nature is often unconfirmed, prognosis is variable, and treatment responses differ significantly.

    • Impact:

    • This review aids in differentiating and managing primary pulmonary lymphoid proliferations.
    • It highlights the importance of accurate diagnosis for appropriate therapeutic strategies.
    • Understanding these distinctions can lead to improved patient outcomes and personalized treatment plans.